Compile Data Set for Download or QSAR
Report error Found 175 Enz. Inhib. hit(s) with all data for entry = 10504
TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  13nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataIC50: 30nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542022(US11273153, Compound 5.21)
Affinity DataKi:  160nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542022(US11273153, Compound 5.21)
Affinity DataKi:  160nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541997(US11273153, Compound 4.5)
Affinity DataIC50: 160nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541997(US11273153, Compound 4.5)
Affinity DataIC50: 160nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541996(US11273153, Compound 4.1)
Affinity DataIC50: 180nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541996(US11273153, Compound 4.1)
Affinity DataIC50: 180nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542009(US11273153, Compound 5.7)
Affinity DataKi:  190nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542009(US11273153, Compound 5.7)
Affinity DataKi:  190nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542021(US11273153, Compound 5.20)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM50295553(4-[4-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-5-pyrid...)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542021(US11273153, Compound 5.20)
Affinity DataKi:  210nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542011(US11273153, Compound 5.9)
Affinity DataKi:  250nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542011(US11273153, Compound 5.9)
Affinity DataKi:  250nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541999(US11273153, Compound 4.17)
Affinity DataIC50: 260nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541999(US11273153, Compound 4.17)
Affinity DataIC50: 260nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataIC50: 270nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataIC50: 270nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542022(US11273153, Compound 5.21)
Affinity DataKi:  470nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542022(US11273153, Compound 5.21)
Affinity DataKi:  470nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541997(US11273153, Compound 4.5)
Affinity DataKi:  560nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541997(US11273153, Compound 4.5)
Affinity DataKi:  560nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541997(US11273153, Compound 4.5)
Affinity DataKi:  560nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541996(US11273153, Compound 4.1)
Affinity DataKi:  600nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542003(US11273153, Compound 3.2)
Affinity DataKi:  600nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541996(US11273153, Compound 4.1)
Affinity DataKi:  600nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542003(US11273153, Compound 3.2)
Affinity DataKi:  600nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542005(US11273153, Compound 5.2)
Affinity DataKi:  630nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542005(US11273153, Compound 5.2)
Affinity DataKi:  630nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542021(US11273153, Compound 5.20)
Affinity DataKi:  660nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542021(US11273153, Compound 5.20)
Affinity DataKi:  660nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542012(US11273153, Compound 5.10)
Affinity DataKi:  670nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542012(US11273153, Compound 5.10)
Affinity DataKi:  670nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  720nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542000(US11273153, Compound 4.18)
Affinity DataKi:  720nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542007(US11273153, Compound 5.3)
Affinity DataKi:  800nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542007(US11273153, Compound 5.3)
Affinity DataKi:  800nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542020(US11273153, Compound 5.19)
Affinity DataKi:  800nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542020(US11273153, Compound 5.19)
Affinity DataKi:  800nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542015(US11273153, Compound 5.14)
Affinity DataKi:  900nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542046(US11273153, Compound 3.50)
Affinity DataKi:  900nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542015(US11273153, Compound 5.14)
Affinity DataKi:  900nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542011(US11273153, Compound 5.9)
Affinity DataKi:  980nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM542011(US11273153, Compound 5.9)
Affinity DataKi:  980nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Everbrilliant Pharma

US Patent
LigandPNGBDBM541999(US11273153, Compound 4.17)
Affinity DataKi:  990nMAssay Description:FP signals were measured with a PHERAstar microplate reader (BMG Labtech) using black, low-binding half-area 96 well plates (Corning). Each binding d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 175 total ) | Next | Last >>
Jump to: